IP Library Granted Patent US 8,551,039
Granted Patent B2
US 8,551,039 · App. 13/076,420 · Granted Oct 8, 2013

Drug delivery with event notification

Inventors: Eric D Veit (Pleasanton, CA); Adam Bylund (Jacksonville, OR); Barry Weber (Livermore, CA); Peter Luther (Pleasanton, CA); Joseph McCluskey (Sharon, MA); Jean Bidegainberry (San Francisco, CA)
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,551,039
App. No.
13/076,420
Filed
Mar 30, 2011
Granted
Oct 8, 2013
Kind
B2
Art Unit
3763
USPC
604/67
Abstract

Devices, systems and methods are provided for drug delivery and the monitoring thereof.

Claims (36)

1. A drug delivery system comprising:

a microprocessor device; and

a drug delivery device separate from the microprocessor device and configured to deliver drug to a user, the drug delivery device including:

a microcontroller connected to a memory unit;

a wireless transmitter connected to the microcontroller so that data is transmitted from the microcontroller to the microprocessor device; and

an event switch connected to the microcontroller so that upon activation of the switch, the microcontroller communicates with the microprocessor to cause the microprocessor device to indicate the user's most recent blood glucose measurement, provide a suggestion for dosage of the drug based on the user's entered input parameters, and recommendation from a health care provider previously stored or entered into a memory of the microprocessor device.

2. The drug delivery system of claim 1 , further comprising a display screen configured to display the user's most recent blood glucose measurement.

3. The drug delivery system of claim 2 , in which the most recent blood glucose measurement comprises one of a most recent pre-prandial and post-prandial blood glucose level.

4. The drug delivery system of claim 1 , in which the microcontroller is configured to record a date and time of activation of the event switch.

5. The drug delivery system of claim 1 , in which the microprocessor device is configured to prompt the user to input other types of information after activation of the event switch.

6. The drug delivery system of claim 5 , in which the other types of information comprises breakfast, lunch, dinner, snack, alcohol, carbohydrates, fats, calories, proteins, medication, pills, insulin, pump bolus, health notes, ketones, HbAlc, Microalbumin, cholesterol, blood pressure, or exercise.

7. The drug delivery system of claim 1 , in which the event switch

comprises a switch selected from the group consisting essentially of a mechanical switch, a magnetic switch, a density switch, a capacitive switch, an electrical sensor, an optical sensor or combinations thereof.

8. The drug delivery system of claim 1 , in which the drug delivery device comprises an insulin pen.

9. The drug delivery system of claim 1 , in which the microprocessor device comprises a device selected from a group consisting of a cell phone, personal-data assistant, computer, watch, or pager.

10. The drug delivery device of claim 1 , in which the microprocessor device comprises a cellular phone.

11. A drug delivery system comprising:

a drug injector preloaded with a drug to be delivered with a sensor to automatically determine an amount of drug dispensed from the injector to relieve a user from logging or recording the amount of drug dispensed;

a blood glucose meter configured to provide a prompt to the user with a suggested dosage based on an algorithm, input from a health care practitioner and other parameters previously entered by the user, upon a blood glucose measurement test by the user; and

a case to store the blood glucose meter, the case being equipped with a detector to detect the presence and removal of the meter from the case so as to determine whether the user has performed a glucose measurement test prior to dosing with the drug injector.

12. A drug delivery system comprising:

a drug injector preloaded with a drug to be delivered with a sensor to automatically determine an amount of drug dispensed from the injector to relieve a user from logging or recording the amount of drug dispensed;

a blood glucose meter configured to provide a prompt to the user with a suggested dosage based on an algorithm, input from a health care practitioner and other parameters previously entered by the user; and

an event switch in communication with the meter so that upon activation of the switch, the meter indicates the user's most recent blood glucose measurement and provides a suggestion for dosage of the drug based on the user's entered input parameters and recommendation from a health care provider previously stored or entered into a memory of the meter.

13. The drug delivery system of any one of claims 11 and 12 , the meter further comprising a display screen configured to display the user's most recent blood glucose measurement.

14. The drug delivery system of claim 13 , in which the most recent blood glucose measurement comprises one of a most recent pre-prandial and post-prandial blood glucose level.

15. The drug delivery device of claim 11 , in which the meter is configured to prompt the user to input other types of information after activation of the detector.

16. The drug delivery system of claim 12 , in which the meter is configured to prompt the user to input other types of information after activation of the event switch.

17. The drug delivery system of any one of claims 16 and 15 , in which the other types of information comprises breakfast, lunch, dinner, snack, alcohol, carbohydrates, fats, calories, proteins, medication, pills, insulin, pump bolus, health notes, ketones, HbAlc, Microalbumin, cholesterol, blood pressure, or exercise.

18. The drug delivery system of claim 11 , in which the detector comprises a switch selected from the group consisting essentially of a mechanical switch, a magnetic switch, a density switch, a capacitive switch, an electrical sensor, an optical sensor or combinations thereof.

19. The drug delivery system of claim 12 , in which the event switch comprises a switch selected from the group consisting essentially of a mechanical switch, a magnetic switch, a density switch, a capacitive switch, an electrical sensor, an optical sensor or combinations thereof.

20. The drug delivery system of any one of claims 11 and 12 , in which the drug injector comprises an insulin pen.

21. The drug delivery system of any one of claims 11 and 12 , in which the meter is configured to request the user to enter and verify the drug dosage information for storage by the meter.

22. The drug delivery system of claim 21 , further comprising a wireless communication device in communication with the meter and configured to automatically transmit dosage amount stored on the meter to an external device.

23. The drug delivery system of claim 22 , in which the external device comprises at least one of a cell phone, PDA, computer, watch, pager, printer, or any other device capable of receiving and/or transmitting wireless communication.

24. The drug delivery system of claim 12 , in which the microcontroller is configured to record a date and time of activation of the event switch.

Assignments (15)
RELEASE OF SECURITY INTEREST Recorded Dec 8, 2025
From: ANKURA TRUST COMPANY, LLC
To: LIFESCAN IP HOLDINGS, LLC
Reel/Frame 073929/0495 →
RELEASE OF SECURITY INTEREST Recorded Dec 8, 2025
From: WILMINGTON SAVINGS FUND SOCIETY, FSB
To: LIFESCAN IP HOLDINGS, LLC
Reel/Frame 073929/0316 →
RELEASE OF SECURITY INTEREST Recorded Dec 8, 2025
From: WILMINGTON SAVINGS FUND SOCIETY, FSBWILMINGTON SAVINGS FUND SOCIETY, FSB
To: LIFESCAN IP HOLDINGS, LLC
Reel/Frame 073928/0626 →
ASSIGNMENT OF PATENT SECURITY INTERESTS (1ST LIEN) Recorded Aug 22, 2025
From: BANK OF AMERICA, N.A.
To: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS SUCCESSOR AGENT
Reel/Frame 072567/0482 →
TRANSFER OF SECURITY AGREEMENT RECORDED AT REEL 063740, FRAME 0080 Recorded Nov 12, 2024
From: BANK OF AMERICA, N.A., AS RESIGNING AGENT
To: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS SUCCESSOR AGENT
Reel/Frame 069340/0243 →
TRANSFER OF SECURITY AGREEMENT RECORDED AT REEL 047179, FRAME 0150 Recorded Nov 11, 2024
From: BANK OF AMERICA, N.A., AS RESIGNING AGENT
To: ANKURA TRUST COMPANY, LLC, AS SUCCESSOR AGENT
Reel/Frame 069314/0022 →
CORRECTIVE ASSIGNMENT TO CORRECT THE PROPERTY LIST BY ADDING PATENTS 6990849;7169116; 7351770;7462265;7468125; 7572356;8093903; 8486245;8066866;AND DELETE 10881560. PREVIOUSLY RECORDED ON REEL 050836 FRAME 0737. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Aug 28, 2023
From: LIFESCAN INC.
To: CILAG GMBH INTERNATIONAL
Reel/Frame 064782/0443 →
RELEASE OF SECOND LIEN PATENT SECURITY AGREEMENT RECORDED OCT. 3, 2018, REEL/FRAME 047186/0836 Recorded Jun 28, 2023
From: BANK OF AMERICA, N.A.
To: LIFESCAN IP HOLDINGS, LLC; JANSSEN BIOTECH, INC.; JOHNSON & JOHNSON CONSUMER INC.
Reel/Frame 064206/0176 →
SECOND LIEN PATENT SECURITY AGREEMENT Recorded May 23, 2023
From: LIFESCAN IP HOLDINGS, LLC
To: BANK OF AMERICA, N.A.
Reel/Frame 063740/0080 →
FIRST LIEN PATENT SECURITY AGREEMENT Recorded May 22, 2023
From: LIFESCAN IP HOLDINGS, LLC
To: BANK OF AMERICA, N.A.
Reel/Frame 063712/0430 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 28, 2019
From: LIFESCAN INC.
To: CILAG GMBH INTERNATIONAL
Reel/Frame 050836/0737 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 28, 2019
From: CILAG GMBH INTERNATIONAL
To: LIFESCAN IP HOLDINGS, LLC
Reel/Frame 050837/0001 →
SECURITY AGREEMENT Recorded Oct 3, 2018
From: LIFESCAN IP HOLDINGS, LLC
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 047186/0836 →
SECURITY AGREEMENT Recorded Oct 2, 2018
From: LIFESCAN IP HOLDINGS, LLC
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 047179/0150 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 30, 2011
From: VEIT, ERIC D.; BYLUND, ADAM; WEBER, BARRY; LUTHER, PETER; MCCLUSKEY, JOSEPH; BIDEGAINBERRY, JEAN
To: LIFESCAN, INC.
Reel/Frame 027303/0848 →
Continuity (4)
Division 12723505 · Mar 12, 2010
Continuation 10981830 · Nov 5, 2004
Provisional Application 60518571 · Nov 6, 2003
Related Publication 20110184343A1 · Jul 28, 2011